Available visualizations
| Visual | Type | Created | Modified |
|---|---|---|---|
|
Risk-of-bias heat map for all studies reporting on adverse health outcomes associated with occupational exposure to cancer chemotherapy agents
|
risk of bias heatmap | 2017-05-16 | 2020-08-25 |
|
Spontaneous abortion associated with occupational exposure to cancer chemotherapy agents associated for studies reporting odds ratios. Number of cases for Valanis et …
|
Data pivot (epidemiology) | 2018-07-20 | 2020-04-01 |
|
Spontaneous abortion associated occupational exposure to cancer chemotherapy: studies reporting percent incidence. Interactive figure and additional study details in HAWC …
|
Data pivot (epidemiology) | 2018-07-12 | 2020-04-01 |
|
Risk-of-bias bar graph for studies reporting on the association of between spontaneous abortion and occupational exposure to cancer chemotherapy agents
|
risk of bias barchart | 2016-10-01 | 2020-08-25 |
|
Risk-of-bias heat map for studies evaluating the association between spontaneous abortion and occupational exposure to cancer chemotherapy agents
|
risk of bias heatmap | 2016-10-01 | 2020-08-25 |
|
Risk of bias of all included studies reporting on genetic toxicity assays of chromosomal aberrations, micronuclei induction or DNA damage …
|
risk of bias barchart | 2017-06-23 | 2020-08-25 |
|
Risk-of-bias heat map for included studies reporting on genetic toxicity, including chromosomal aberrations, micronuclei induction, and DNA damaged measured by …
|
risk of bias heatmap | 2017-06-23 | 2020-08-25 |
|
Percent of lymphocytes with structural chromosomal aberrations (excluding gaps) associated with occupational exposure to cancer chemotherapy agents. Data are analyzed …
|
Data pivot (epidemiology) | 2016-05-25 | 2020-04-01 |
|
Percent of lymphocytes with structural chromosomal aberrations (excluding gaps) associated with occupational exposure to cancer chemotherapy agents. Data presented as …
|
Data pivot (epidemiology) | 2017-04-02 | 2020-04-01 |
|
Number of chromosomal aberrations (excluding gaps) per 100 lymphocytes scored associated with occupational exposure to cancer chemotherapy agents. Two studies …
|
Data pivot (epidemiology) | 2017-05-14 | 2020-04-01 |
|
Risk-of-bias bar graph for studies reporting on structural chromosomal aberrations associated with occupational exposure to cancer chemotherapy agents
|
risk of bias barchart | 2017-07-19 | 2020-08-25 |
|
Risk-of-bias heat map for all studies reporting on structural chromosomal aberrations associated with cancer chemotherapy agents
|
risk of bias heatmap | 2017-07-19 | 2020-08-25 |
|
Number of cells with micronuclei/1,000 cells scored associated with occupational exposure to cancer chemotherapy agents: binucleated lymphocytes
|
Data pivot (epidemiology) | 2016-06-15 | 2020-04-01 |
|
Number of cells with micronuclei/1,000 cells scored associated with occupational exposure to cancer chemotherapy agents: buccal cells
|
Data pivot (epidemiology) | 2016-04-06 | 2020-04-01 |
|
Number of micronuclei per 1,000 cells scored associated with occupational exposure to cancer chemotherapy agents: binucleated lymphocytes. An additional study …
|
Data pivot (epidemiology) | 2017-04-14 | 2020-04-01 |
|
Number of micronuclei per 1,000 cells scored associated with occupational exposure to cancer chemotherapy agents: buccal cells
|
Data pivot (epidemiology) | 2016-06-14 | 2020-04-01 |
|
Risk-of-bias bar graph for all studies reporting on micronuclei (MN) induction associated with occupational exposure to cancer chemotherapy agents, including …
|
risk of bias barchart | 2017-07-19 | 2020-08-25 |
|
Risk-of-bias heat map for all studies reporting on micronuclei induction associated with occupational exposure to cancer chemotherapy agents
|
risk of bias heatmap | 2017-07-19 | 2020-08-25 |
|
Percent of tail DNA measured by comet assay associated with occupational exposure to cancer chemotherapy agents: studies reporting values in …
|
Data pivot (epidemiology) | 2016-06-03 | 2020-04-01 |
|
Percent of tail DNA measured by comet assay associated with occupational exposure to cancer chemotherapy agents: studies reporting higher than …
|
Data pivot (epidemiology) | 2016-06-03 | 2020-04-01 |
|
Tail length (μm) measured by comet assay associated with occupational exposure to cancer chemotherapy agents. An additional study reported a …
|
Data pivot (epidemiology) | 2017-05-31 | 2020-04-01 |
|
Tail moment measured by comet assay associated with occupational exposure to cancer chemotherapy agents for (A) studies in the expected …
|
Data pivot (epidemiology) | 2016-06-08 | 2020-04-01 |
|
Tail moment measured by comet assay associated with occupational exposure to cancer chemotherapy agents: (B) studies in higher than the …
|
Data pivot (epidemiology) | 2016-07-29 | 2020-04-01 |
|
DNA damage index measured by comet assay associated with occupational exposure to cancer chemotherapy agents: mean comet score. In addition, …
|
Data pivot (epidemiology) | 2017-05-16 | 2020-04-01 |
|
DNA damage index measured by comet assay associated with occupational exposure to cancer chemotherapy agents: mean number of cells per …
|
Data pivot (epidemiology) | 2017-06-03 | 2020-04-01 |
|
Risk-of-bias bar graph for studies reporting on DNA damage measured by comet assay, including % tail DNA, tail length, tail …
|
risk of bias barchart | 2017-07-19 | 2020-08-25 |
|
Risk-of-bias assessment heat map for included studies reporting DNA damage measured by comet assay associated with cancer chemotherapy agents, including …
|
risk of bias heatmap | 2017-07-17 | 2020-08-25 |
|
Risk-of-bias assessment bar graph for acute effects associated with occupational exposure to cancer chemotherapy agents
|
risk of bias barchart | 2016-09-10 | 2020-08-25 |
|
Risk-of-bias assessment heat map of studies evaluating acute effects associated with occupational exposure to cancer chemotherapy agents
|
risk of bias heatmap | 2016-09-10 | 2020-08-25 |
|
Risk-of-bias bar graph for studies reporting on cancer associated with occupational exposure to cancer chemotherapy
|
risk of bias barchart | 2017-07-22 | 2020-08-25 |
|
Risk-of-bias heat map for studies reporting on cancer associated with occupational exposure to cancer chemotherapy agents
|
risk of bias heatmap | 2016-12-09 | 2020-08-25 |
|
Risk-of-bias assessment bar graphs for studies assessing immune effects associated with cancer chemotherapy agents
|
risk of bias barchart | 2016-10-14 | 2020-08-25 |
|
Risk-of-bias heatmap for studies reporting immune effects associated with occupational exposure to cancer chemotherapy agents
|
risk of bias heatmap | 2016-08-08 | 2020-08-25 |
|
Risk-of-bias bar graph for studies reporting on kidney, liver or cardiotoxicity associated with occupational exposure to cancer chemotherapy agents
|
risk of bias barchart | 2017-07-23 | 2020-08-25 |
|
Risk-of-bias heat map for studies reporting on kidney, liver or cardiotoxicity associated with occupational exposure to cancer chemotherapy agents
|
risk of bias heatmap | 2017-07-23 | 2020-08-25 |
|
Risk-of-bias bar graph for studies reporting on reproductive and developmental toxicity, other than spontaneous abortion, associated with occupational exposure to …
|
risk of bias barchart | 2017-07-22 | 2020-08-25 |
|
Risk-of-bias for studies reporting on reproductive and developmental toxicity, other than spontaneous abortion, associated with occupational exposure to cancer chemotherapy …
|
risk of bias heatmap | 2017-07-22 | 2020-08-25 |
37 visuals found.